Voyager Acquisition Corp (VRXAW)
VRXAW Stock Price Chart
Explore Voyager Acquisition Corp interactive price chart. Choose custom timeframes to analyze VRXAW price movements and trends.
VRXAW Company Profile
Discover essential business fundamentals and corporate details for Voyager Acquisition Corp (VRXAW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
10 Jun 2026
Employees
—
Website
https://www.veraxa.comCEO
Christoph Antz
Description
Veraxa Biotech AG is a clinical-stage biopharmaceutical company specializing in next-generation antibody-based cancer therapies. [9] The company is advancing a drug discovery and development engine for ADCs and other novel antibody-based therapy concepts. [14] It was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL). [8, 14]
VRXAW Financial Timeline
Browse a chronological timeline of Voyager Acquisition Corp corporate events including earnings releases, dividend announcements, and stock splits.
VRXAW Stock Performance
Access detailed VRXAW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
